Shanghai Shen Lian Biomedical Corporation
SHH: 688098.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dongsheng Nie
- Employees
- 380
- Headquarters
- Shanghai, China
- IPO year
- 2019
- Market cap
- CN¥3.6B
- Website
- https://www.slbio.com.cn
Loading 688098…
Loading profile data…Frequently asked questions about 688098
What does Shanghai Shen Lian Biomedical Corporation (688098.SS) do?
Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.
Where does 688098.SS trade?
Shanghai Shen Lian Biomedical Corporation (688098.SS) trades on the Shanghai Stock Exchange.
What sector is 688098.SS in?
Shanghai Shen Lian Biomedical Corporation (688098.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Shanghai Shen Lian Biomedical Corporation?
Dongsheng Nie is the chief executive officer of Shanghai Shen Lian Biomedical Corporation (688098.SS).
Where is Shanghai Shen Lian Biomedical Corporation headquartered?
Shanghai Shen Lian Biomedical Corporation is headquartered in China.
Does 688098.SS pay a dividend?
Yes — Shanghai Shen Lian Biomedical Corporation (688098.SS) paid a trailing twelve-month dividend of CNY 0.04 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688098.SS go public?
Shanghai Shen Lian Biomedical Corporation (688098.SS) completed its initial public offering in 2019.